These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 2028861)
21. MR imaging of the normal and abnormal clivus. Kimura F; Kim KS; Friedman H; Russell EJ; Breit R AJR Am J Roentgenol; 1990 Dec; 155(6):1285-91. PubMed ID: 2122682 [TBL] [Abstract][Full Text] [Related]
22. MR imaging of the normal meninges: comparison of contrast-enhancement patterns on 3D gradient-echo and spin-echo images. Farn JW; Mirowitz SA AJR Am J Roentgenol; 1994 Jan; 162(1):131-5. PubMed ID: 8273651 [TBL] [Abstract][Full Text] [Related]
23. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Mahfouz AE; Hamm B; Taupitz M; Wolf KJ Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554 [TBL] [Abstract][Full Text] [Related]
24. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients. Haustein J; Laniado M; Niendorf HP; Louton T; Beck W; Planitzer J; Schöffel M; Reiser M; Kaiser W; Schörner W Radiology; 1993 Mar; 186(3):855-60. PubMed ID: 8430199 [TBL] [Abstract][Full Text] [Related]
27. Arterial-phase three-dimensional contrast-enhanced MR angiography of the carotid arteries. Levy RA; Prince MR AJR Am J Roentgenol; 1996 Jul; 167(1):211-5. PubMed ID: 8659374 [TBL] [Abstract][Full Text] [Related]
28. Dynamic gadolinium-enhanced MR imaging of the spleen: normal enhancement patterns and evaluation of splenic lesions. Mirowitz SA; Brown JJ; Lee JK; Heiken JP Radiology; 1991 Jun; 179(3):681-6. PubMed ID: 2027974 [TBL] [Abstract][Full Text] [Related]
29. Contrast-enhanced gradient-echo MR imaging of the head and neck: experimental and clinical assessment. Mihara F; Gupta KL; Joslyn JN Radiat Med; 1994; 12(4):147-51. PubMed ID: 7809407 [TBL] [Abstract][Full Text] [Related]
30. Rheumatoid arthritis of the knee: value of gadopentetate dimeglumine-enhanced MR imaging. Adam G; Dammer M; Bohndorf K; Christoph R; Fenke F; Günther RW AJR Am J Roentgenol; 1991 Jan; 156(1):125-9. PubMed ID: 1898545 [TBL] [Abstract][Full Text] [Related]
32. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients. Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044 [TBL] [Abstract][Full Text] [Related]
33. Accuracy of staging rectal tumors with contrast-enhanced transrectal MR imaging. Vogl TJ; Pegios W; Mack MG; Hünerbein M; Hintze R; Adler A; Lobbeck H; Hammerstingl R; Wust P; Schlag P; Felix R AJR Am J Roentgenol; 1997 Jun; 168(6):1427-34. PubMed ID: 9168702 [TBL] [Abstract][Full Text] [Related]
34. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images. Ross MR; Schomer DF; Chappell P; Enzmann DR AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208 [TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced echo-planar MR imaging of myocardial perfusion: preliminary study in humans. Edelman RR; Li W Radiology; 1994 Mar; 190(3):771-7. PubMed ID: 8115626 [TBL] [Abstract][Full Text] [Related]
36. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects. Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831 [TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine. Jung HW; Chang KH; Choi DS; Han MH; Han MC AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513 [TBL] [Abstract][Full Text] [Related]
38. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction. Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611 [TBL] [Abstract][Full Text] [Related]
39. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine. Bauner KU; Reiser MF; Huber AM Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911 [TBL] [Abstract][Full Text] [Related]
40. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]